Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    TransCode Therapeutics In...

    NASDAQ: RNAZ · Real-Time Price · USD
    10.39
    -0.11 (-1.05%)
    At close: Aug 19, 2025, 10:21 AM

    TransCode Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a 98.61K 42.47K
    Gross Profit
    		 n/a n/a -98.61K -42.47K
    Operating Income
    		 -15.66M -19.42M -18.67M -6.15M
    Interest Income
    		 684.00 5.29K 20.41K 664.00
    Pretax Income
    		 -16.79M -18.55M -17.56M -6.84M
    Net Income
    		 -16.75M -18.55M -35.13M -6.94M
    Selling & General & Admin
    		 5.95M 7.15M 8.43M 3.4M
    Research & Development
    		 9.62M 12.26M 10.23M 2.75M
    Other Expenses
    		 n/a 0.00 -1.08M -278.33K
    Operating Expenses
    		 15.66M 19.42M 17.59M 5.87M
    Interest Expense
    		 26.81K 55.9K 17.56M 95.07K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -15.66M 19.42M 17.59M 5.87M
    Income Tax Expense
    		 n/a n/a 17.56M 95.07K
    Shares Outstanding (Basic)
    		 356.12K 5.42K 16.22K 10.53K
    Shares Outstanding (Diluted)
    		 356.12K 5.42K 16.22K 10.53K
    EPS (Basic)
    		 -47.14 -3.45K -73.19K -648
    EPS (Diluted)
    		 -47.14 -3.45K -1.08K -648
    EBITDA
    		 -16.19M -17.97M -17.47M -6.11M
    EBIT
    		 -14.57M -18.49M -17.56M -6.15M
    Depreciation & Amortization
    		 534.86K 516.75K 98.61K 42.47K

    Add to Watchlist